Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Non Operating Income (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Non Operating Income data on record, last reported at -$71000.0 in Q4 2025.

  • For Q4 2025, Non Operating Income rose 30.39% year-over-year to -$71000.0; the TTM value through Dec 2025 reached -$456000.0, down 46.15%, while the annual FY2025 figure was -$456000.0, 46.15% down from the prior year.
  • Non Operating Income reached -$71000.0 in Q4 2025 per TLSI's latest filing, up from -$94000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $3.5 million in Q1 2022 and bottomed at -$349000.0 in Q4 2022.
  • Average Non Operating Income over 4 years is $406180.2, with a median of -$42000.0 recorded in 2024.
  • The widest YoY moves for Non Operating Income: up 68.32% in 2024, down 705.26% in 2024.
  • A 4-year view of Non Operating Income shows it stood at -$349000.0 in 2022, then increased by 7.74% to -$322000.0 in 2023, then soared by 68.32% to -$102000.0 in 2024, then soared by 30.39% to -$71000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were -$71000.0 in Q4 2025, -$94000.0 in Q3 2025, and -$40000.0 in Q2 2025.